Posted by Michael Wonder on 09 Feb 2019
U.S. PhRMA's fight to prevent lower Canadian drug prices
9 February 2019 - Drug industry turns up heat against Canada's drug price reforms.
Offers of voluntary price freezes, backroom meetings with the powerful U.S. drug lobby, and rising industry rhetoric — those are some of the glimpses that emerged this week into the pharmaceutical industry's fight against Canada's plan to lower drug prices.
"This show of muscle is because drug companies are getting very scared about this," said Marc-André Gagnon, a pharmaceutical policy researcher at Carleton University in Ottawa.
